Inventor · disambiguated record
Ramakrishna Nirogi
Also filed as: NIROGI RAMAKRISHNA
38 granted patents·9 pending applications·44 citations·filing 2008–2025
95Inventor score
Top patents by PatentIndex Score
47 records- 0189US9957257B2Amide compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 1, 2018·12 cites·9 claims
- 0281US9540321B2Process for large scale production of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrateSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Jan 10, 2017·5 cites·12 claims
- 0378US9079894B2Heteroaryl compounds as 5-HT4 receptor ligandsNIROGI RAMAKRISHNA·Filed 2012·Granted Jul 14, 2015·5 cites·14 claims
- 0478US8318725B2Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted Nov 27, 2012·2 cites·5 claims
- 0577US2024277690A1New uses of a 5-ht4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0677US2024293389A1Method of treating cognitive deficits associated with schizophreniaSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0776US8003670B2Aminoalkoxy aryl sulfonamide compounds and their use as 5-HT6 ligandsSUVEN LIFE SCIENCES LTD·Filed 2008·Granted Aug 23, 2011·4 cites·8 claims
- 0875US10294217B2Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 21, 2019·1 cites·8 claims
- 0973US11040026B2Muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2017·Granted Jun 22, 2021·1 cites·16 claims
- 1073US10005711B2Process for large scale production of 1-isopropyl-3-{5-[1-(3-methoxypropyl)piperidin-4-YL]-[1,3,4]oxadiazol-2-YL}-1H-indazole oxalateSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Jun 26, 2018·2 cites·14 claims
- 1171US12285421B2Uses of a 5-HT4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2019·Granted Apr 29, 2025·0 cites·4 claims
- 1271US9079888B2Compounds as histamine H3 receptor ligandsNIROGI RAMAKRISHNA·Filed 2011·Granted Jul 14, 2015·4 cites·15 claims
- 1371US8735423B2Bicyclic compounds as α4β2 nicotinic acetylcholine receptor ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted May 27, 2014·2 cites·8 claims
- 1468US10308620B2Muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Jun 4, 2019·1 cites·16 claims
- 1568US9328092B2Acrylamide compounds as histamine H3 receptor ligandsSUVEN LIFE SCIENCES LTD·Filed 2012·Granted May 3, 2016·1 cites·6 claims
- 1667US9802896B2Process for large scale production of N-[4-(1-cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acetamide dihydrochlorideSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Oct 31, 2017·1 cites·16 claims
- 1766US9636335B2Heteroaryl compounds as 5-HT4 receptor ligandsSUVEN LIFE SCIENCES LTD·Filed 2015·Granted May 2, 2017·1 cites·21 claims
- 1863US12338236B2Benzoisothiazole and benzoisoxazole compounds for the treatment of mental disordersSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Jun 24, 2025·0 cites·5 claims
- 1963US8653071B2α4β2 neuronal nicotinic acetylcholine receptor ligandsNIROGI RAMAKRISHNA·Filed 2010·Granted Feb 18, 2014·1 cites·9 claims
- 2061US12391698B2Substituted piperidines and piperazines and methods for the treatment of CNS disordersSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Aug 19, 2025·0 cites·15 claims
- 2160US2025352540A1Uses of a pure 5-ht6 receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2025·Application pending·0 cites
- 2259US9018231B2Sulfone compounds as 5-HT6 receptor ligandsNIROGI RAMAKRISHNA·Filed 2010·Granted Apr 28, 2015·1 cites·12 claims
- 2358US12275746B2Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2023·Granted Apr 15, 2025·0 cites·7 claims
- 2454US10010527B2Active metabolite of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate and dimesylate dihydrate salt of active metaboliteSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Jul 3, 2018·0 cites·15 claims
- 2553US8598204B21,2-dihydro-2-oxoquinoline compounds as 5-HT4 receptor ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted Dec 3, 2013·0 cites·6 claims
- 2652US12122779B2Pyrrolo-pyridazine derivatives as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2019·Granted Oct 22, 2024·0 cites·12 claims
- 2752US8404720B2Aryl sulfonamide amine compounds and their use as 5-HT6 ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted Mar 26, 2013·0 cites·11 claims
- 2851US2022409614A1Treating behavioral and psychological symptoms in dementia patientsSUVEN LIFE SCIENCES LTD·Filed 2020·Application pending·0 cites
- 2949US12397003B2Amorphous pharmaceutical compositions of abiraterone acetateSUVEN LIFE SCIENCES LTD·Filed 2020·Granted Aug 26, 2025·0 cites·20 claims
- 3049US11458135B2Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Oct 4, 2022·0 cites·38 claims
- 3149US2021346374A1Pharmaceutical compositions of 5-ht6 receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2021·Application pending·0 cites
- 3248US11116764B2Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Sep 14, 2021·0 cites·24 claims
- 3347US11253514B2Triple combination of pure 5-HT6 receptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Feb 22, 2022·0 cites·16 claims
- 3447US10973831B2Fluoropiperidine compounds as pure 5-HT 6 receptor antagonistsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Apr 13, 2021·0 cites·11 claims
- 3547US2023000859A1Methods for treating behavioral and psychological symptoms in patients with dementiaSUVEN LIFE SCIENCES LTD·Filed 2020·Application pending·0 cites
- 3646US2021338661A1New uses of a pure 5-ht 6 receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2018·Application pending·0 cites
- 3745US9790211B25-amino-quinoline-8-carboxamide derivatives as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2013·Granted Oct 17, 2017·0 cites·20 claims
- 3843US11278530B2Polycyclic amides as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Mar 22, 2022·0 cites·19 claims
- 3943US10603323B2Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitorsSUVEN LIFE SCIENCES LTD·Filed 2017·Granted Mar 31, 2020·0 cites·26 claims
- 4043US9951045B2Indazole compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2014·Granted Apr 24, 2018·0 cites·7 claims
- 4142US12156871B2Substituted azacycles as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Dec 3, 2024·0 cites·9 claims
- 4242US11622967B2Method of treatment with histamine-3 receptor inverse agonistSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Apr 11, 2023·0 cites·17 claims
- 4342US11234979B2Heteroaryl compounds as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2018·Granted Feb 1, 2022·0 cites·18 claims
- 4441US2019336509A1Triple combination of histamine-3 receptor inverse agonists, acetylcholinesterase inhibitors and nmda receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2017·Application pending·0 cites
- 4539US2019336497A1Pharmaceutical compositions of 5-ht6 antagonistSUVEN LIFE SCIENCES LTD·Filed 2017·Application pending·0 cites
- 4627US8912179B2Heterocyclyl compounds as histamine H3 receptor ligandsNIROGI RAMAKRISHNA·Filed 2010·Granted Dec 16, 2014·0 cites·12 claims
- 4725US8551718B2Functional assay for 5-HT2A, histamine H1 or adrenergic alpha 1B receptorsAHMAD ISHTIYAQUE·Filed 2010·Granted Oct 8, 2013·0 cites·3 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →